By participating in this survey, you will be contributing to important research that will help us assess the usefulness of the WFH SDM Tool for the global community. Additionally, you may find out more about your own decision-making process—whether as a person with hemophilia, caregiver, or healthcare professional.
Eligibility criteria:
- Healthcare professionals who manage people living with hemophilia, people living with hemophilia A or B, and caregivers and/or family members of people living with hemophilia are invited to participate
- Participants must be willing to review the WFH SDM Tool prior to starting the survey
The survey will take about 10 to 20 minutes to complete. It’s available in English, French, Spanish, Japanese, German, and Dutch. Your responses are anonymous, and participation is voluntary. For more information about the survey, read our Participant Information sheet here.
Thank you for taking the time to share your valuable insights with the World Federation of Hemophilia.
If you have questions about the survey or the WFH SDM Tool, please contact us at [email protected]. To find out more about the WFH Shared Decision-Making (SDM) Tool, click here.
The WFH thanks our Corporate Partners BioMarin Pharmaceutical Inc., CSL Behring, F. Hoffmann-La Roche, Novo Nordisk, Pfizer, Sanofi and Sobi.